Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial (Q41613250)

From Wikidata
Jump to navigation Jump to search
scientific article published on 5 December 2014
edit
Language Label Description Also known as
English
Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial
scientific article published on 5 December 2014

    Statements

    Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial (English)
    Fabien Zoulim
    Carol Stanciu
    Federico Guillermo Villamil
    Jacob George
    Elisabeth Dammers
    Darryl Kurland
    Oliver Lenz
    Sivi Ouwerkerk-Mahadevan
    Thierry Verbinnen
    Jane Scott
    Wolfgang Jessner
    5 December 2014

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit